Yue D K, Hanwell M A, Satchell P M, Turtle J R
Diabetes. 1982 Sep;31(9):789-94. doi: 10.2337/diab.31.9.789.
This study examined the effects of an aldose reductase inhibitor (CP 45634, Sorbinil, Pfizer, New York, New York) on the neuropathy of streptozotocin-induced diabetic rats. Sorbinil treatment for 4 wk reduced sciatic nerve sorbitol concentration and improved motor nerve conduction velocity in diabetes of 2-9 mo duration. It remains to be determined whether Sorbinil can prevent chronic diabetic neuropathy.
本研究检测了一种醛糖还原酶抑制剂(CP 45634,索比尼尔,辉瑞公司,纽约)对链脲佐菌素诱导的糖尿病大鼠神经病变的影响。对病程为2至9个月的糖尿病大鼠进行4周的索比尼尔治疗,可降低坐骨神经山梨醇浓度,并改善运动神经传导速度。索比尼尔是否能预防慢性糖尿病神经病变仍有待确定。